These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1524947)

  • 1. [Fluoroquinolones: a new era in antibiotic therapy?].
    Fiaccadori F
    Ann Ital Med Int; 1992; 7(1):46-50. PubMed ID: 1524947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of the fluoroquinolone antibiotics.
    Just PM
    Pharmacotherapy; 1993; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fluoroquinolones--antibacterial activity, pharmacokinetics and indications for a new group of chemotherapeutic drugs].
    Naumann P; Dopp C
    Internist (Berl); 1989 Jan; 30(1):20-31. PubMed ID: 2646237
    [No Abstract]   [Full Text] [Related]  

  • 4. Ciprofloxacin and norfloxacin, two fluoroquinolone antimicrobials.
    Nix DE; DeVito JM
    Clin Pharm; 1987 Feb; 6(2):105-17. PubMed ID: 3311572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrophobicity and serum sensitivity of Klebsiella pneumoniae treated with sub-MICs of quinolones.
    Hostacká A
    Microbios; 1997; 91(368-369):137-43. PubMed ID: 9523422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of action of and resistance to ciprofloxacin.
    Hooper DC; Wolfson JS; Ng EY; Swartz MN
    Am J Med; 1987 Apr; 82(4A):12-20. PubMed ID: 3034057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to quinolones in pathogens causing urinary tract infections.
    Kapoor H; Aggarwal P
    J Commun Dis; 1997 Sep; 29(3):263-7. PubMed ID: 9465532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The quinolones: decades of development and use.
    Emmerson AM; Jones AM
    J Antimicrob Chemother; 2003 May; 51 Suppl 1():13-20. PubMed ID: 12702699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high incidence of ciprofloxacin resistance in urinary isolates in eastern Nepal.
    Srinivasa H; Parija SC; Bhattacharya S; Sehgal R
    J Commun Dis; 1999 Mar; 31(1):45-7. PubMed ID: 10810586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
    Ismaeel NA; Tayeb OS
    Microbios; 1993; 74(300):147-54. PubMed ID: 8396196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enoxacin: a new fluoroquinolone.
    Jaber LA; Bailey EM; Rybak MJ
    Clin Pharm; 1989 Feb; 8(2):97-107. PubMed ID: 2645085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of fluoroquinolones against gram-positive bacteria.
    Bush K; Goldschmidt R
    Curr Opin Investig Drugs; 2000 Sep; 1(1):22-30. PubMed ID: 11249591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fluoroquinolone antimicrobials: structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity.
    Vancutsem PM; Babish JG; Schwark WS
    Cornell Vet; 1990 Apr; 80(2):173-86. PubMed ID: 2180631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New fluoroquinolones in urology].
    Derevianko II; Hefedova LA
    Urologiia; 2004; (4):27-32. PubMed ID: 15457949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norfloxacin and silver-norfloxacin as topical antimicrobial agents: results of in vitro susceptibility testing against bacteria and Candida sp isolated from burn patients.
    Holder IA; Knoll CA; Wesselman J
    J Burn Care Rehabil; 1986; 7(6):479-83. PubMed ID: 3429479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial resistance to the quinolone antimicrobial agents.
    Hooper DC; Wolfson JS
    Am J Med; 1989 Dec; 87(6C):17S-23S. PubMed ID: 2690616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro evaluation of lomefloxacin].
    Dette GA; Knothe H
    Arzneimittelforschung; 1989 Aug; 39(8):832-5. PubMed ID: 2818672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoroquinolones in animal health.
    Brown SA
    J Vet Pharmacol Ther; 1996 Feb; 19(1):1-14. PubMed ID: 8992019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological activity and synthetic metodologies for the preparation of fluoroquinolones, a class of potent antibacterial agents.
    Da Silva AD; De Almeida MV; De Souza MV; Couri MR
    Curr Med Chem; 2003 Jan; 10(1):21-39. PubMed ID: 12570719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthesis and antibacterial activity of pyridonecarboxylic acid derivatives containing 2-methyl-5-nitroimidazol].
    Ye FQ; Chen L; Huang JM
    Yao Xue Xue Bao; 2003 Apr; 38(4):260-3. PubMed ID: 12889123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.